Character, Habit and Taste of woman with coldeness in their bodies

冷え性の発現は寒冷刺激に対する血管運動性体温調節と密接に関係しているが,患者の性格･生活習慣･食事の嗜好等にも関わっていると考えられる｡そこで今回は冷え性婦人100名を対象にCMl調査と35項目にのぼるアンケート調査を行った｡その結果,冷え性の増悪因子として,日頃の運動不足･神経症的性格傾向･過労･食べ物の嗜好がクローズアップされ,この面での生活指導が冷え性の治療を行っていく上で,薬物的な治療と並んで重要であることか示唆された。The character, habit and taste were studied about by means of a questionnaire survey and Cornell Medical Index in 100 women who felt cold in their part of bodies. More than 30% of the women showed the neurotic personality, They had a tendency to dislike the greasy foods, and frequently had sweet foods. More than 50% of them ordinally complained of shoulder stiffness and generalfatigue. The women who played sports weekly were less than 20%. The neurotic porsonality, the tendency to dislike the greasy foods and the lack of exercise were seemed to be the feature of their character, taste, and habit. Thus, improvement of their personality and life style may have a good effect on the coldness in women

Prevalence of urinary stress incontinence in women

三朝分院外来を訪れた女性患者を対象に尿失禁に関する18項目のアンケート調査を行った。その結果，全体の過半数が尿失禁の経験者であった。腹圧性尿失禁が大部分を占め，高齢になるほど　経産回数が多いほど頻度が高くなる傾向がみられた。そのうちの約1割に尿漏れの頻度と程度が重かった。以上より，尿失禁について積極的な啓蒙，診断，治療の必要性が認められた。The prevalence of urinary stress incontinence was investigated in 93 women consulting in our hospital by means of a questionnaire survey. The survey showed that 52.7% of the total cases experienced the loss of urine. 87% of the cases with the loss of urine were the cases with stress incotinence. The prevalence of incontinence increased with age up to 69.2% in the 60's. A positive correlation was found between the number of childbirths and the prevalence of incontinence

The efficacy of maternity swimming to reduce mother's weight

第1報において妊婦水泳に関する妊婦の認識について報告し (1) ,第2報において妊婦水泳の現状とその適応について報告した (2) ｡その後,第3報において妊婦水泳が母児の循環系におぼす影響について報告し (3) ,第4報にて出産後1年間の児の予後調査を行った (4) 。今回は,妊婦水泳による体重減少効果について検討を行った。その結果,妊婦水泳前後で平均460gの体重減少がみられた｡また水泳を10回以上行った妊婦において,水泳を行っている期間の体重増加が水泳を行っていない期間の体重増加に比べて有意に少なかった｡これより,妊婦水泳には一定の減量効果があり,肥満妊婦の治療にも応用できると考えられた。The efficacy of awimming to reduce mother's weight were studided retrospectively in 107 women. Each time they swum for a hour. They were given a chance of swimming at only one time in a week. Most of them reduced their weight after the swimming. The average of the weight loss was 460 gram after each time of swimming. In women who had a chance of swimming at ten times or more, the mother's weight gain in a week when they had a chance of swimming, was statistically (p<0.01) less than the weight in a week when they didn't swim. Thus, the maternity swimming was thought to have the efficacy to reduce mother's weight. If the maternlty swimming is clinically applied for the treatment of obese pregnant women, their weight will reduce efficiently

Maternity swimmlng at Misasa Hospital of Okayama University Medical School. Second report. The indication and its practice.

第一報において，当科外来通院妊婦を対象とした妊婦水泳に関するアンケート調査の結果を報告1）したが，その結果にもとづき，1988年2月より妊婦水泳を開始し，11カ月を経過した。この間，初産婦および前回難産経験をもつ経産婦を主たる対象として，積極的に水泳を奨めた結果，18例の妊婦水泳を経験することができた。その結果，流早産例は1例もなく，児の予後も良好であり，妊婦管理の一環としての妊婦水泳の安全性と有用性が確認できたので，当科における妊婦水泳の現状とその適応につき報告する。From February to December, 1988, 18 cases of maternity swimming were deliverd at Misasa hospital of Okayama university medical school. Then we discussed the indication, safety and effectiveness of maternity swimmmg. (Results) (1) Fifteen cases (83.3%) were primiparas and 5 cases (27.8%) were 30 years old or more. (2) As for the weeks of pregnancy at the beginning of swimming, the earliest one was at 18 weeks and the latest one was at 37 weeks. (3) The times of swimming during pregnancy were variou in each case, and the maxirnum one was 20 times and the minimum one was 2 times. (4) There was no abortion and premature delivery. (5) There was no low birth weight infant and no asphxia of the newborn. (Conclusion) The inducement of maternity swimming is safe and effective to the management of pregnancy, especially to the cases of primipara, old aged or having minor disturbance

Maternal swimming at Misasa Hospital Of Okayama University Medical School First report. Recognition of the pregnant women to maternity swimming

妊婦のスポーツに対する考え方は近年まで比較的消極的であったが，最近マスコミに取り上げられるようになり，妊婦水泳・エアロビクスダンス等は全国的にもかなり普及していると思われる。今回外来通院患者を対象に妊婦水泳に関するアンケート調査を行った結果，大多数のものが関心を持ち，また実施希望を持っていることが判明したのでその概要を報告する。The sports have been contraindication for pregnant women till resent years. Since Dr. Murooka reported the safety and the effectiveness of maternity swimming in 1978. maternity swimming have been taken up and fasionarised by mass media. And then maternity swimming becomes popular in our all over the country. Now we made inquiries about maternity swimming to 25 pregnant women in our outpatients clinic. (Results) 1. Eightyfour percent of them were interested in maternity swimming. 2. Eightyeight percent of them wanted to swim. 3. Most of them had little knowledge about tocological effectiveness of maternity swimming. (Conclusion) It is nessesary that the enlightenment and the active management of maternity swimming by obstetricians

Maternity swimming at M isasa Hospital of Okayama University Medical School-Fourth report. The growth and development of babies who were born from the mothers who experienced the maternity swimming

第1報において妊婦水泳に関する妊婦の認識について報告し，第2報において妊婦水泳の現状とその適応について報告し，第3報にて妊婦水泳が循環器系に与える影響について報告した。今回は，母親が妊婦水泳を行い出生後1年以上経過した児の発育，発達状況についてアンケート調査を行った。その結果，発育e発達状況は艮好であった。現時点で全例正常な発達をしていた。このことより我々の行っている妊婦水泳は児の発育，発達に悪影響を及ぼさないことが確かめられた。Seventy babies were born from the mothers who experienced maternity swimming in our hospital. The growth and development of 31 babies that were over 1 years old were investigated by means of a questionnaire survey. 62.5% of the total were answered. This survey showed that no babies had problems with their growth and development. These results suggest that maternal Swimmingmight have no hazardous effects on the fetus

Dietary supplementation in bronchial asthma. Suppression of the generation of leukotrienes by N-3 fatty acids.

N-3系脂肪酸の気管支喘息に対する有用性が示唆されているが,その評価は定まっていない｡今回,5人の気管支喘息患者に対しN-3系脂肪酸であるαリノレン酸を豊富に含有するエゴマ油を用いた食事療法を行い,臨床症状,ピークフロー値,末梢白血球からのロイコトリエン産生能,血漿リン脂質中の脂肪酸組成につき検討を行った｡2週間の食事療法の前後でピークフロー値は有意な改善を示し(p<0.05),カルシウムイオノファー刺激によるロイコトリエン(LT)産生能は治療前後でLTB4が77.6ng/5×106cellsから41.6ng/5×10(6)cells(p<0.05)に,LTC4は64.0ng/5×10(6)cellsから38･8ng/5×10(6)cells(p<0.05)とともに有意な改善を認めた。また血漿リン脂質中のN-3系脂肪酸(αリノレン酸,エイコサペンタエン酸,ドコサヘキサエン酸)も有意な上昇を認めた。以上よりN-3系脂肪酸(エゴマ油)を用いた食事療法の有用性が示唆された｡The therapeutic trials using N-3 fatty acids such as fish oil have been reported in patients with bronchial asthma, while its effect is still controversial. The effects of dietary supplementation with perilla seed oil rich in alpha-linolenic acid (α-LNA), parent n-3 fatty acid, were studied in five patients with asthma. The symptoms of asthma and mean peak flow rates (PFR) both early in the morning and in the evening were improved 2 weeks after the dietary supplementation and the increases of peak flow rates were significant (p<0.05). The generation of leukotriene B4 (LB4) by peripheral leukocytes stimulated with Ca ionophore A23187 was significantly suppressed from 77.6 ng/5×10(6) cells to 41.6ng/5×10(6) cells by the supplementation (P<0.05). The generation of leukotriene C4 (LTC4) by leukocytes was also significantly suppressed from 64.0 ng/5×10(6) cells to 38.8ng/5×10(6) cells after the manipulation with perilla seed oil (P<0.05). The concentration of N-3 fatty acids (such as α-LNA,　eicosapentaenoic, and docosahekisaenoic acids) in plasma phospholipid increased significantly after the dietary supplementation (P<0.05). These results suggest that dietary supplementation with perilla seed oil is beneficial for the treatment of asthma

気管支喘息におけるエゴマ油と白血球のロイコトリエンB4,C4合成

In recent years, it has been noted that there is a close correlation between leukotrienes and late asthmatic reaction (LAR). In this study, effects of dietary supplementation with perilla seed oil rich in alpha-linolenic acid, which is speculated to affect the generation of leukotrienes through metabolism of arachidonic acid (AA), were evaluated in 6 patients with asthma. The symptoms and ventilatory function were improved after 2-week dietary supplementation with perilla seed oil. The generation of LTB4 and LTC4 by peripheral leucocytes stimulated with Ca ionophore A23187 was significantly suppressed by the dietary supplementation (LTB4 and LTC4 ; p<0.05). Regarding the composition of fatty acids in serum phospholipids, the concentrations of eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), and AA tended to increase after the supplementation, accompanied with an increase in the ratio of EPA to AA. These results suggest that dietary supplementation with perilla seed oil brings beneficial effects in the treatment of asthma.近年,ロイコトリエンと遅発型気管支反応(LAR)との密接な関連が注目されている｡本論文では,アラキドン酸(AA)代謝を通してロイコトリエン合成に関与すると推定される,αリノレン酸を多く含むエゴマ油による食事療法の臨床効果を,気管支喘息を対象に検討した｡臨床症状および換気機能は,2週間のエゴマ油投与で明らかな改善差傾向を示した｡Ca ionophore A23187刺激時の白血球のLTB4およびLTC4産生は,エゴマ油投与により,投与前に比べ有意の減少を示した(p<0.05)｡血中脂肪酸に関しては,イエイコサペンタエン酸(EPA),ドコサヘキサエン酸(DHA)およびAA濃度は,エゴマ油投与により増加傾向を示し,同時にEPA/AA比も増加する傾向が見られた｡以上の結果より,エゴマ油による食事療法は,治療上有用であると考えられた

The effects of perilla seed oil ointment for atopic dermatitis

近年アトピー性皮膚炎が増加しており,工ゴマ油を使った食事療法がアレルギー抑制に有用であることが報告されている｡そこで今回,エゴマ油を外用剤として使用するため,亜鉛華単軟膏を基剤とした工コマ軟膏を作製し,アトピー性皮膚炎患者3例を対象にその臨床応用を試みた｡その結果,掻痒感の軽減に効果がみられ,また皮膚症状では,丘疹.表皮剥離,苔癬化,落屑などの所見が改善される傾向が見られた｡The perilla seed oil contains rich α-linolenic acid (α-LNA), parent n-3 fatty acid. The dietary intake of n-3 fatty acid, such as perilla seed oil, has been reported to have some clinical effects in patients with allergic disease. In this report, we prepared the perilla seed oil ointment for atopic dermatitis and the effects of the ointment was evaluated in three patients with atopic dermatitis. This ointment suppressed skin itch, and improved papules, excoriation, lichenification and desquamation of the skin. These results suggest that the perilla seed oil ointment has some effectiveness including suppression of inflammatory changes of the skin in patients with atopic dermatitis

Japanese Lung Cancer Society Guidelines for Stage IV NSCLC With EGFR Mutations

Patients with NSCLC in East Asia, including Japan, frequently contain EGFR mutations. In 2018, we published the latest full clinical practice guidelines on the basis of those provided by the Japanese Lung Cancer Society Guidelines Committee. The purpose of this study was to update those recommendations, especially for the treatment of metastatic or recurrent EGFR-mutated NSCLC. We conducted a literature search of systematic reviews of randomized controlled and nonrandomized trials published between 2018 and 2019 that multiple physicians had reviewed independently. On the basis of those studies and the advice from the Japanese Society of Lung Cancer Expert Panel, we developed updated guidelines according to the Grading of Recommendations, Assessment, Development, and Evaluation system. We also evaluated the benefits of overall and progression-free survival, end points, toxicities, and patients’ reported outcomes. For patients with NSCLC harboring EGFR-activating mutations, the use of EGFR tyrosine kinase inhibitors (EGFR TKIs), especially osimertinib, had the best recommendation as to first-line treatment. We also recommended the combination of EGFR TKI with other agents (platinum-based chemotherapy or antiangiogenic agents); however, it can lead to toxicity. In the presence of EGFR uncommon mutations, except for an exon 20 insertion, we also recommended the EGFR TKI treatment. However, we could not provide recommendations for the treatment of EGFR mutations with immune checkpoint inhibitors, including monotherapy, and its combination with cytotoxic chemotherapy, because of the limited evidence present in the literature. The 2020 Japanese Lung Cancer Society Guidelines can help community-based physicians to determine the most appropriate treatments and adequately provide medical care to their patients